Soudy, Rania
Kimura, Ryoichi
Patel, Aarti
Fu, Wen
Kaur, Kamaljit
Westaway, David http://orcid.org/0000-0003-1928-4616
Yang, Jing
Jhamandas, Jack
Funding for this research was provided by:
Alberta Innovates | Alberta Innovates - Health Solutions
Department of Medicine Translational Research Fellowship
KAKENHI (Grants-in-Aid for Scientific Research
Canadian Network for Research and Innovation in Machining Technology, Natural Sciences and Engineering Research Council of Canada
Alberta Innovates | Alberta Innovates Bio Solutions (201600006)
Alberta Prion Research Institute
Gouvernement du Canada | Canadian Institutes of Health Research (PJT159746)
Alzheimer's Society of Alberta and NWT Alberta Prion Research Institute University Hospital Foundation
Article History
Received: 6 March 2019
Accepted: 12 July 2019
First Online: 29 July 2019
Change Date: 28 April 2022
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1038/s41598-022-10922-5
Competing Interests
: The corresponding author (JJ, University of Alberta) has filed the following patents related to this manuscript: United States Patent Application Serial No. 15/705,789 and Canada Application Serial No. 2,967,616. Inventors are: Jhamandas, Jack; Soudy, Rania; Kaur, Kamaljit; Fu, Wen; MacTavish, David and Patel, Aarti. Title: Brain Penetrant Amylin Receptor Based Peptides for Alzheimer’s Disease. The patent relates to the generation and application of short amylin receptor antagonist peptides that are used in the studies described in this manuscript.